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 ABSTRACT 
The structural assignment of differently substituted quinolones / coumarins was reviewed using 
1
H NMR spectral data. In 
case of quinolones / coumarins, with varied substitutions at C-4 and different positions of the benzenoid ring, there is a 
great variation in the 
1
H NMR value of the proton only attached with C-3. It was observed that when different substitutions 
(methyl / amino / hydroxy / acetoxy / trifluoromethyl) were carried out at C-4 position, maximum deshielding with the proton 
attached with C-3 was observed with trifluoromethyl substitution. The observation is same even with the variation in 
different groups at the benzenoid ring.   
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1. INTRODUCTION 
Quinolones and coumarins are the important heterocyclic system present in biologically active alkaloids (Fig. 1).
[1-4]
 As 
part of our ongoing research on the synthesis of differently substituted heterocyclic compounds with potential antioxidant 
and anti-inflammatory activities,
[5-8]
 we were interested in synthesizing the derivatives of quinolones / coumarins containing 
different substituents on benzenoid ring as well as C-4 position of the heterocyclic ring.  
As these moieties are more frequently incorporated in molecules of biological value, special attention has been paid to the 
effect of various substituents (trifluomethyl / methoxy / hydroxy / amino / acetoxy / nitro / fluoro). In the present work, we 
have described the effect of substitution at C-4 position as well as benzenoid ring on the δ value of proton attached with C-
3 position using 
1
H NMR.  
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Figure 1 
2. RESULTS & DISCUSSION 
Our route to synthesis of quinolones and coumarins was based on Knorr reaction and Pechmann synthesis respectively 
between anisidines / phenols and ethyl acetoacetate / ethyl trifluoromethyl acetoacetate (Scheme 1) which were 
submitted to a sequence of reactions, thereby generating different derivatives of quinolones / coumarins.
[8,9] 
 
Application of standard NMR technique to the quinolone / coumarin analogues allowed complete 
1
H assignment to be 
made. The effect of various substituents at C-4 position as well as benzenoid ring on the δ value was found to be 
significant in case of proton attached with C-3 position rather than other positions. 
In case of quinolones bearing different substituents at C-4 position (1-5), the appearing trend is that trifluoromethyl 
substitution (5) results in maximum deshielding of H-3 position than other substituents at C-4 position (Table 1). It is worth 
noting that as compared to C-4 methyl group (1), the substitution of hydroxy (3) or amino groups (2) causes shielding 
effect on H-3. It is also seen that acetylation at C-4 (4) results in deshielding of δ value. Following these promising 
observations, the proposed discriminative tool was also checked for other structurally related quinolone / coumarin 
analogues where variation was carried out on the benzenoid ring.  
In case of C-4 methyl quinolone / coumarin derivatives bearing methoxy (6a, 11a and 19a), hydroxy / amino (7a, 9a, 12a, 
17a and 19b), acetoxy / urethane groups (8a, 10a, 13a, 16a, 18a and 19c), fluoro (14a) and nitro (15a) groups on the 
benzenoid ring, deshielding was noticed for the proton attached with C-3, in case of either acetoxy or fluoro substituent on 
the benzenoid ring but to a very lesser extent (Table 2). It has been observed that the replacement of methoxy group by 
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hydroxy group on the benzenoid ring causes upfield effect, whereas opposite effect was observed on the incorporation of 
acetoxy group in place of hydoxy group and this deshielding due to acetoxy group is even more than methoxy group.   
Studies were extended with a view to examine the influence of trifluoromethyl group at C-4 position in place of methyl 
group. It was observed that the substitution of C-4 methyl group with trifluoromethyl group has a great influence on the 
1
H 
NMR shift of the H-3 proton. To illustrate this substitution dependence, one can just compare the 
1
H NMR data of C-4 
methyl analogues with those of C-4 trifluoromethyl derivatives having different substitutions on benzenoid ring. The 
structural assignments for compounds are reported in Table 2.  
In the present report, it is clearly evident that when C-4 methyl group gets replaced with trifluoromethyl, the δ value for H-3 
becomes downfield. It was also observed that in compound 13b, the δ value for H-3 was found to be highly deshielded 
i.e., 8.01 ppm; ∆δ being 1.55 ppm which is quite significant. The deshielding effect is also noteworthy in case of nitro 
substituted quinolone, 15a-b (∆δ = 1.06) rather than fluoro, 14a-b (∆δ = 0.63) or amino, 9a-b (∆δ = 0.38), 17a-b (∆δ = 
0.48) analogues. 
 
 
Table 1.  Effect of substitution at C-4 on 
1
H NMR δ values (ppm) 
Structure 
 
No. 
 
 
H-3 H-5 H-7 H-8 H-6 
 
1
[10]
 6.39 (s) 7.69 (d,  
J = 8.1 Hz) 
7.49 (m) 7.29 (d, 
J = 8.1 Hz) 
7.18 (m) 
H
N O
NH2  
2
[11]
 5.44 (s) 7.86 (d,  
J = 8.0 Hz) 
7.43 (t,  
J = 7.8 Hz) 
7.22 (d,  
J = 8.3 Hz) 
7.08 (t,  
J = 7.8 Hz) 
 
H
N O
OH  
3
[8]
 5.76 (s)  
 
 
-------7.11-7.78 -------  
(m) 
 
H
N O
OAc  
4
[8]
 6.65 (s)  
 
 
-------7.22-7.66 ------- 
(m) 
 
H
N O
CF3  
5
[12]
 6.97 (s) 7.63 (ddd, J = 1.4, 
7.3 & 7.8 Hz) 
7.68-7.71 (m) 7.43 (d, 1H, J = 
8.3 Hz) 
 
7.30 (ddd, J = 1.0, 7.3 
& 8.3 Hz) 
 
 
 
 
 
 
 
 
 
 
H 
N O 
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Table 2. 
1
H NMR δ values (ppm) of different quinolone / coumarin derivatives 
 
 
Structure Compound H-3 H-5 H-6 / H-7 H-8 
 
 
 
H
N
R
OH3CO
 
6a
[8]
  R = CH3 6.30 (s)  7.66 (d,  
J = 8.9 Hz) 
6.84 (d,  
J = 8.7 Hz) 
6.94 (s) 
6b
[9]
  R = CF3 6.77 (s) 7.61(d,  
J = 8.4 Hz) 
--------6.92-6.96--------(m) 
 
 
H
N
R
OHO
 
7a
[8]
  R = CH3 6.08 (s) 7.45 (d,  
J = 8.8 Hz) 
6.59 (d,  
J = 8.8 Hz) 
6.65 (d,  
J = 2.4 Hz) 
7b
[9]
  R = CF3 6.68 (s) ----6.76-6.82----(m) 7.53 (dd,  
J = 2.1 & 8.7 Hz) 
----6.76-6.82----(m) 
 
H
N
R
OAcO
 
8a
[8]
  R = CH3 6.39 (s) 7.73 (d,  
J = 6.1 Hz) 
6.98 (dd,  
J = 2.4 & 6.2 Hz) 
7.05 (s) 
8b
[9]
  R = CF3 6.97 (s) 7.73 (d,  
J = 8.7 Hz) 
7.12 (dd,  
J = 1.8 & 8.7 Hz) 
7.19 (d,  
J = 1.8 Hz) 
 
H
N
R
OH2N
 
9a
[9]
  R = CH3 5.96 (s) 7.34 (d,  
J = 8.7 Hz) 
6.46 (d, 
 J = 8.4 Hz) 
6.37 (s) 
9b
[9]
  R = CF3 6.34 (s) 7.26 (d,  
J = 6.9 Hz) 
6.47 (d, 
 J = 8.4 Hz) 
6.37 (s) 
 
 
H
N
R
OAcHN
 
10a
[9]
  R = CH3 6.26 (s) 7.62 (d,  
J = 8.7 Hz) 
7.30 (d,  
J = 8.7 Hz) 
7.99 (s) 
10b
[9]
  R = CF3 6.79 (s) 7.62 (d,  
J = 8.7 Hz) 
7.35 (d,  
J = 9.0 Hz) 
7.98 (s) 
 
 
H
N
H3CO
O
R  
11a
[8]
  R = CH3 6.39 (s) -----7.13-7.18----- (m) 7.26 (dd, J = 1.8 & 
7.5 Hz) 
11b
[9]
  R = CF3 7.13 (s) -----7.48-7.82-----(m) 7.95 (br s) 
 
 
H
N
HO
O
R  
12a
[8]
  R = CH3 
 
6.36 (s) -----7.00-7.17-----(br s) 
12b
[9]
  R = CF3  7.04 (s) -----7.19-7.34-----(m) 7.95 (d,  
J = 6.6 Hz) 
 
H
N
AcO
O
R  
13a
[8]
  R = CH3 6.46 (s) -----7.29-7.35----- (m) 7.47 (dd, J = 1.5 & 
5.3 Hz) 
13b
[9]
  R = CF3 8.01 (s) 7.98 (d,  
J = 2.1 Hz) 
7.81(dd,  
J = 2.1 & 9.0 Hz) 
8.29 (br s, J = 9.3 
Hz) 
 14a
[13]  
R = CH3 6.17 (s) 7.22 (s) 7.53 (d,  7.66 (d, 
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H
N
F
O
R  
J = 7.7 Hz)  J = 7.6 Hz) 
14b
[14]  
R = CF3 7.08 (s) 7.41 (d,  
J = 9.5 Hz) 
7.59 (ddd, J = 4.6, 8.4 
& 9.2 Hz) 
7.49 (dd, J = 4.9 & 
9.1 Hz) 
 
 
 
H
N
O2N
O
R  
15a
[13]
 R = CH3 6.14 (s) 7.41 (s) 7.78 (d,  
J = 7.6 Hz) 
7.65 (d,  
J = 7.4 Hz) 
15b
[12]
 R = CF3 
 
 
 
 
 
7.20 (s) 8.43 (s) 8.45 (dd,  
J = 2.4 & 8.8 Hz) 
7.57 (d,  
J = 8.8 Hz) 
 
O O
R
H
NO
O
 
16a
[9]
   R = CH3  6.22 (s) 7.67 (d,  
J = 8.7 Hz) 
7.40 (d,  
J = 8.7 Hz) 
7.54 (s) 
16b
[9]
   R = CF3 6.61 (s) 7.58 (d,  
J = 9.0 Hz) 
7.48 (dd,  
J = 1.5 & 9.0 Hz) 
7.76 (d, 
 J = 1.5 Hz) 
 
O O
R
H2N
 
17a
[9]
   R = CH3 5.88 (s) 7.38  
(d, J = 8.8 Hz) 
---6.53-6.54---(m) 6.39 (s) 
17b
[9]
   R = CF3 6.36 (s)  ---7.37-7.41---(m) 6.64 (dd, 
 J = 2.3 & 8.7 Hz) 
6.54 (d,  
J = 2.2 Hz) 
 
O O
R
AcHN
 
18a
[9]
   R = CH3 6.25 (s) 7.70 (d,  
J = 8.7 Hz) 
7.45 (d,  
J = 8.4 Hz) 
7.75 (s) 
18b
[9]
   R = CF3 6.89 (s) -----7.53-7.67-----(m) 7.91 (s) 
 
 
 
H
N O
R
R
 
19a
[8]
   R = OMe 
 
19b
[8]
   R = OH 
 
19c
[8]
   R = OAc 
6.42 (s) 7.14-7.15 (m, H-5 & 
H-7) 
-----7.27-7.30----- (m, H-6) 
 
6.34 (s) -----6.89-6.98-----(m, H-5 & H-6) 7.10 (d, J = 7.8 Hz, 
H-7) 
6.27 (s)  7.12 (d, J = 7.7 Hz) 7.01 (t, J = 7.9 Hz, H-
6) 
7.43 (d, J = 7.9 Hz, 
H-7) 
 
 
 
3. EXPERIMENTAL 
In the case of compounds prepared in our laboratory, 
1
H NMR was recorded on Bruker Avance-300 spectrometer in 
DMSO-d6 as the solvent and TMS as internal reference. Solvent DMSO > 99.80% pure, was from Aldrich.  
Chemical shifts (δ scale) are reported in parts per million (ppm) relative to the central peak of the solvent, i.e. 2.5 ppm for 
DMSO-d6. 
1
H NMR parameters are as follows: spectrometer frequency (SF), 300.13 MHz; acquisition time (AQ), 5.3084 s; number of 
transients (NS), 16; receiver gain (RG), 287.4; temperature (TE), 300.0 K; dwell time (DW), 81 μs; per scan delay (DE), 
6.0 μs; dummy scans (DS), 2. 
 
ISSN 2321-807X 
1712 | P a g e                                                         A p r i l  0 5 ,  2 0 1 4  
3.1. General procedure for the synthesis of methoxy-4-methylquinolin-2-ones  
Anisidine (20 g, 164 mmol) was added drop wise to trifluoromethyl/ethyl acetoacetate (277 mmol) and the reaction mixture 
was refluxed for 20 h. After the completion of reaction, the contents were cooled and then poured on sodium carbonate 
solution. The compound was extracted with chloroform and the solvent was evaporated in vacuo. 70 % Sulphuric acid (40 
mL) was added and the reaction mixture was stirred at 95 
o
C. The progress of reaction was monitored on TLC (5% 
methanol–chloroform). On completion of the reaction, the solution was cooled and poured on crushed ice (500 g). The 
resulting precipitate was filtered and washed with water and petroleum ether. The crude product was recrystallized from 
ethanol to give methoxy quinolin-2-ones. 
3.1.1. 7-Methoxy-4-methylquinolin-2(1H)-one (6a) 
It was obtained as white solid (83 %); mp: 195 
o
C, (Literature value = 196 
o
C)
15
; 
1
H NMR (DMSO-d6, 300 MHz): δ 2.45 (s, 
3H, C-4 CH3), 3.88 (s, 3H, OCH3), 6.30 (s, 1H, H-3), 6.84 (d, 1H, J = 8.7 Hz, H-6), 6.94 (s, 1H, H-8), 7.66 (d, 1H, J = 8.9 
Hz, H-5), 11.00 (brs, 1H, NH); 
13
C NMR (DMSO-d6, 75 MHz): δ 19.36 (C-4 CH3), 56.14 (OCH3), 99.12, 111.12 (C-6 and C-
8), 114.68 (C-3), 118.56 (C-10), 127.02 (C-5), 141.26 (C-9), 148.85 (C-4), 161.80 (C-7), 162.89 (C-2); IR (KBr) νmax: 
2957.41, 1658.97, 1629.05, 1549.71, 1474.57, 1417.53, 1261.70, 1217.14, 1177.11, 1023.59, 856.63, 808.71, 710.74 cm
-
1
; UV (methanol) λmax: 323 and 337 nm; HRMS: C11H11O2N [M]
+
: 189.9665. 
3.1.2. 6-Methoxy-4-methylquinolin-2(1H)-one (11a) 
It was obtained as white solid (75 %); mp: 260-262 
o
C, (Literature value = 260-262 
o
C)
16
; 
1
H NMR (DMSO-d6, 300 MHz): δ 
2.42 (s, 3H, C-4 CH3), 3.82 (s, 3H, OCH3), 6.39 (s, 1H, H-3), 7.13-7.18 (m, 2H, H-5 and H-7), 7.26 (dd, 1H, J = 1.8 & 5.3 
Hz,  H-8),  11.46 (brs, 1H, NH); 
13
C NMR (DMSO-d6, 75 MHz): δ 19.45 (C-4 CH3), 56.37 (OCH3), 107.69, 117.52 (C-5 and 
C-7), 119.87 (C-10), 121.06 (C-8), 122.11 (C-9), 131.38 (C-3), 148.27 (C-4), 154.96 (C-6), 162.03 (C-2); IR (KBr) νmax: 
3433.06, 2821.76, 1653.70, 1621.98, 1503.71, 1421.31, 1275.63, 1240.22, 1202.18, 1179.30, 1044.05, 835.98, 628.40 
cm
-1
; UV (methanol) λmax: 269 and 350 nm; HRMS: C11H11O2N [M]
+
: 189.8188. 
3.1.3. 8-Methoxy-4-methylquinolin-2(1H)-one (19a) 
It was obtained as white solid (30 %); mp: 192-194 
o
C, (Literature value = 188-190 
o
C)
17
; 
1
H NMR (DMSO-d6, 300 MHz): δ 
2.41 (s, 3H, C-4 CH3), 3.89 (s, 3H, OCH3), 6.42 (s, 1H, H-3), 7.14-7.15 (m, 2H, H-5 and H-7), 7.27-7.30 (m, 1H, H-6), 
10.58 (brs, 1H, NH); 
13
C NMR (DMSO-d6, 75 MHz): δ 18.74 (C-4 CH3), 56.07 (OCH3), 110.89, 116.36 (C-5 and C-7), 
120.08 (C-9), 121.36, 121.57 (C-3 and C-6), 128.57 (C-10), 145.80 (C-4), 148.15 (C-8), 161.14 (C-2); IR (KBr) νmax: 
3163.95, 2933.15, 1648.26, 1605.82, 1462.84, 1389.90, 1265.97, 1154.88, 1049.33, 860.83, 791.04, 739.93, 726.00, 
636.77 cm
-1
; UV (methanol) λmax: 278 and 335 nm; HRMS: C11H11O2N [M]
+
: 189.7739. 
3.1.4. 6-Methoxy-4-(trifluoromethyl)quinolin-2(1H)-one (11b)   
The product was obtained through column chromatography in ethyl acetate/petroleum ether (1:49). The title compound 
(11b) was obtained as yellow solid in 70% yield by following the general procedure. Melting point: 270
o
C; 
1
H NMR 
(DMSO-d6, 300 MHz): δ 3.72 (s, 3H, -OCH3), 7.13 (s, 1H, H-3), 7.48-7.82 (m, 2H, H-5 and H-7), 7.95 (brs, 1H, H-8) and 
12.14 (brs, 1H, NH); 13C NMR (DMSO-d6, 75.5 MHz):  δ 55.53 (-OCH3), 99.12, 100.01 (C-7 and C-5), 114.68 (C-3), 
122.18 and 123.69 (C-8 and C-9), 130.67 (C-10), 143.96 (C-4), 144.06-145.09 (-CF3), 157.89 (C-6) and 161.55 (C-2); 
HRMS: Calculated for C11H8F3NO2 [M]
+.
 243.1819, found 243.5345.  
7-Methoxy-4-(trifluoromethyl)quinolin-2(1H)-one (6b)  
The title compound (6b) was obtained through column chromatography in ethyl acetate/petroleum ether (1:49). It was 
obtained by as yellow solid in 80% yield following the general procedure. Melting point: 250-252
o
C, 
1
H NMR (DMSO-d6, 
300 MHz):  δ 3.84 (s, 3H, -OCH3), 6.77 (s, 1H, H-3), 6.92-6.96 (m, 2H, H-6 and H-8), 7.61 (d, 1H, J = 8.4 Hz, H-5) and 
12.20 (brs, 1H, NH); 13C NMR (DMSO-d6, 75.5 MHz): δ 55.54 (-OCH3), 99.79, 107.01 (C-6 and C-8), 112.00 (C-3), 
118.13 (C-10), 124.37 (C-5), 125.64 (C-9), 136.23-136.64 (-CF3), 141.75 (C-4), 160.38 (C-7) and 161.63 (C-2); HRMS: 
Calculated for C11H8F3NO2 [M+H]
+
 244.1819, found 244.3801. 
3.2. General procedure for the synthesis of hydroxy-4-methylquinolin-2-ones  
A mixture of hydrobromic acid and acetic acid (7:3) was added to methoxy-4-methyl-1H-quinolin-2-ones. The reaction 
mixture was refluxed for 75 h and then poured on crushed ice. The resulting precipitate was filtered and washed with 
water to yield 3-alkyl-7-hydroxyquinolin-2-ones.
18
  
3.2.1. 7-Hydroxy-4-methylquinolin-2(1H)-one (7a) 
It was obtained as white solid (85 %); mp: >300 
o
C, (Literature value = 306-307 
o
C)
19
; 
1
H NMR (DMSO-d6, 500 MHz): δ 
2.28 (s, 3H, C-4 CH3), 6.08 (s, 1H, H-3), 6.59 (d, 1H, J = 8.8 Hz, H-6), 6.65 (d, 1H, J = 2.4 Hz, H-8), 7.45 (d, 1H, J = 8.8 
Hz, H-5), 10.02 (brs, 1H, OH), 11.33 (brs, 1H, NH); 
13
C NMR (DMSO-d6, 125 MHz): δ 19.03 (C-4 CH3), 100.61, 111.80 (C-
6 and C-8), 113.32 (C-3), 117.50 (C-10), 126.68 (C-5), 141.04 (C-9), 148.44 (C-4), 159.95 (C-7), 162.69 (C-2); IR (KBr) 
νmax: 3425.24, 2927.52, 2364.39, 1652.89, 1541.56 (amide-II), 1474.84, 1406.35, 1255.85, 1220.96, 1074.07, 905.44, 
817.60, 689.94 cm
-1
; UV (methanol) λmax: 324 and 337 nm; HRMS: C10H9O2N [M+H]
+
: 176.2008. 
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3.2.2. 6-Hydroxy-4-methylquinolin-2(1H)-one (12a) 
It was obtained as white solid (80 %); mp: 324-326 
o
C, (Literature value = 326-330 
o
C)
20
; 
1
H NMR (DMSO-d6, 300 MHz): δ 
2.34 (s, 3H, C-4 CH3), 6.36 (s, 1H, H-3), 7.00 (brs, 2H, H-5 and H-7), 7.17 (brs, 1H,  H-8),  9.40 (brs, 1H, OH), 11.42 (brs, 
1H, NH); 
13
C NMR (DMSO-d6, 75 MHz): δ 19.36 (C-4 CH3), 109.41, 117.43 (C-5 and C-7), 120.39 (C-10), 121.09 (C-8), 
121.80 (C-9), 132.74 (C-3), 148.01 (C-4), 152.93 (C-6), 161.99 (C-2); IR (KBr) νmax: 3489.59, 3187.46, 1661.73, 1634.87, 
1608.22, 1513.42, 1433.01, 1294.34, 1191.88, 866.12, 853.10, 810.02, 642.28 cm
-1
; UV (methanol) λmax: 269 and 352 nm; 
HR MS: C10H9O2N [M]
+
: 175.7805. 
3.2.3. 8-Hydroxy-4-methylquinolin-2(1H)-one (19b) 
It was obtained as white solid (70 %); mp: 250-254 
o
C, (Literature value = 248 
o
C)
21
; 
1
H NMR (DMSO-d6, 300 MHz): δ 2.37 
(s, 3H, C-4 CH3), 6.34 (s, 1H, H-3), 6.89-6.98 (m, 2H, H-5 and H-6), 7.10 (d, 1H, J = 7.8 Hz, H-7), 10.25 (brs, 2H, NH and 
OH); 
13
C NMR (DMSO-d6, 75 MHz): δ 18.70 (C-4 CH3), 114.36, 114.96 (C-5 and C-7), 120.48 (C-9), 121.04, 121.60 (C-3 
and C-6), 127.84 (C-10), 143.67 (C-4), 148.19 (C-8), 160.91 (C-2); IR (KBr) νmax: 3401.25, 1639.37, 1601.19, 1553.68, 
1478.15, 1398.60, 1288.58, 1208.23, 1145.95, 924.47, 861.73, 792.88, 735.68, 600.31 cm
-1
; UV (methanol) λmax: 254, 279 
and 336 nm; HRMS: C10H9O2N [M]
+
: 175.9968. 
3.2.4. 6-Hydroxy-4-(trifluoromethyl)quinolin-2(1H)-one (12b)  
The title compound (12b) was obtained as yellow solid in 70% yield by following the general procedure. Melting point: 268 
o
C; 
1
H NMR (DMSO-d6, 300 MHz):  δ 7.04 (s, 1H, H-3), 7.19-7.34 (m, 2H, H-5 and H-7), 7.95 (d, 1H, J = 6.6 Hz, H-8), 
10.29 (brs, 1H, OH), 11.96 (brs, 1H, NH); 13C NMR (DMSO-d6, 75.5 MHz):  δ 99.54 and 102.94 (C-5 and C-7), 119.95 (C-
3), 122.69 and 123.45 (C-8 and C-9), 130.70 (C-10), 143.04 (C-4), 144.02-144.48 (-CF3), 156.27 (C-6), 161.11 (C-2); 
HRMS: Calculated for C10H6F3NO2 [M+H]
+
 230.0423, found 230.0424.  
 
3.2.5. 7-Hydroxy-4-(trifluoromethyl)quinolin-2(1H)-one (7b)  
The title compound (7b) was obtained as yellow solid in 70% yield by following the general procedure. Melting point: > 300 
o
C ;  
1
H NMR (DMSO-d6, 300 MHz):  δ 6.68 (s, 1H, H-3), 6.76-6.82 (m, 2H, H-5 and H-8), 7.53 (dd, 1H, J = 2.1 and 8.7 Hz, 
H-6), 10.57 (brs, 1H, OH) and 12.08 (brs, 1H, NH); 13C NMR (DMSO-d6, 75.5 MHz): δ 100.70 and 106.05 (C-6 and C-8), 
112.89 (C-3), 117.04 (C-10), 120.80 (C-5), 124.44 (C-9), 125.75 (C-4), 136.34-136.75 (-CF3), 141.86 (C-7) and 160.45 (C-
2); HRMS: Calculated for C10H6F3NO2 [M+H]
+
 230.0423, found 230.0428.  
 
3.3.  General procedure for the synthesis of 4-methyl-2-oxo-1,2-dihydroquinolin-yl acetate  
A solution of acetic anhydride and acetic acid (1:4) was added to 3-alkyl-hydroxy-4-methylquinolin-2(1H)-ones 10-18. The 
reaction mixture was refluxed for 6 hr and then poured on crushed ice. The resulting precipitate was filtered and washed 
with water to yield acetoxy-3-alkylquinolin-2-ones.  
3.3.1. 4-Methyl-2-oxo-1,2-dihydroquinolin-7-yl acetate (8a) 
It was obtained as white solid (90 %); mp: 258 
o
C, (Literature value = 257-258 
o
C); 
1
H NMR (DMSO-d6, 500 MHz): δ 2.30 
(s, 3H, C-4 CH3), 2.42 (s, 3H, OCOCH3), 6.39 (s, 1H, H-3), 6.98 (dd, 1H, J = 2.4 & J = 6.2 Hz, H-6), 7.05 (s, 1H, H-8), 7.73 
(d, 1H, J = 6.1 Hz, H-5), 11.67 (brs, 1H, NH); 
13
C NMR (DMSO-d6, 125 MHz): δ 19.38 (C-4 CH3), 21.76 (OCOCH3), 
108.77, 116.71 (C-6 and C-8), 118.36 (C-3), 121.21 (C-10), 126.98 (C-5), 140.43 (C-9), 148.52 (C-4), 152.59 (C-7), 
162.63 (C-2), 169.82 (-OCOCH3); IR (KBr) νmax: 2927.12, 2855.27, 1751.47, 1678.55, 1561.24, 1510.88, 1458.53, 
1362.63, 1232.32, 116 6.29, 1025.06, 906.26, 856.71, 645.56 cm
-1
; UV (methanol) λmax: 323 and 335 nm; HRMS: 
C12H11O3N [M]
+
: 217.2915. 
3.3.2. 4-Methyl-2-oxo-1,2-dihydroquinolin-6-yl acetate (13a) 
It was obtained as white solid (85 %); mp: 270 
o
C; 
1
H NMR (DMSO-d6, 300 MHz): δ 2.30(s, 3H, C-4 CH3), 2.40 (s, 3H, 
OCOCH3), 6.46 (s, 1H, H-3), 7.29-7.35 (m, 2H, H-5 and H-7), 7.17 (dd, 1H,  J = 1.5 & 7.5 Hz,  H-8),  11.71 (brs, 1H, NH); 
13
C NMR (DMSO-d6, 75 MHz): δ 18.39 (C-4 CH3), 20.76 (OCOCH3), 116.27, 117.06 (C-5 and C-7), 120.01 (C-10), 121.47 
(C-8), 124.63 (C-3), 136.38 (C-9), 144.72 (C-4), 147.43 (C-6), 161.45 (C-2), 169.53 (OCOCH3); IR (KBr) νmax: 3433.37, 
2835.40, 1751.37, 1656.34, 1559.57, 1502.72, 1425.27, 1373.09, 1212.40, 1166.23, 1135.37, 1012.90, 905.94, 871.27, 
842.91, 683.29 cm
-1
; UV (methanol) λmax: 264 and 334 nm; HRMS: C12H11O3N [M+H]
+
: 218.4582. 
3.3.3. 4-Methyl-2-oxo-1,2-dihydroquinolin-8-yl acetate (19c) 
It was obtained as white solid (85 %); mp: 242-244 
o
C; 
1
H NMR (DMSO-d6, 300 MHz): δ 2.19 (s, 3H, C-4 CH3), 2.25 (s, 
3H, OCOCH3), 6.27 (s, 1H, H-3), 7.01 (t, 1H, J = 7.9 Hz, H-6), 7.12 (d, 1H, J = 7.7 Hz, H-5), 7.43 (d, 1H, J = 7.9 Hz, H-7), 
11.27 (brs, 1H, NH); 
13
C NMR (DMSO-d6, 75 MHz): δ 18.68 (C-4 CH3), 21.35 (OCOCH3), 121.19 (C-9), 121.23, 121.48 
(C-7 and C-3), 122.36, 123.84 (C-5 and C-6), 131.54 (C-10), 136.74 (C-4), 148.00 (C-8), 161.63 (C-2), 169.64 (OCOCH3); 
IR (KBr) νmax: 3431.86, 2996.30, 1763.12, 1671.14, 1647.83, 1605.69, 1475.41, 1422.01, 1366.81, 1195.13, 1168.09, 
1138.04, 1016.39, 932.32, 869.41, 744.18, 689.19 cm
-1
; UV (methanol) λmax: 268 and 328 nm; HRMS: C12H11O3N [M+H]
+
: 
218.1072. 
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3.3.4.  2-Oxo-4-(trifluoromethyl)-1,2-dihydro-6-yl acetate (13b)  
The title compound (13b) was obtained as white crystals in 90% yield by following the general procedure. Melting point: 
296 
o
C; 1H NMR (DMSO-d6, 300 MHz): δ 2.37 (s, 3H, -OCOCH3), 7.81 (dd, 1H, J = 2.1 and 9.0 Hz, H-7), 7.98 (d, 1H, J = 
2.1 Hz, H-5), 8.01 (s, 1H, H-3), 8.29 (brs, 1H, J = 9.3 Hz, H-8); 13C NMR (DMSO-d6, 75.5 MHz):  δ 20.88 (-OCOCH3), 
110.36, 113.19 (C-7 and C-5), 119.30 (C-3), 123.53 (C-8), 128.06 (C-9), 131.20 (C-10), 146.23-147.18 (-CF3), 150.65 (C-
4), 155.69 (C-6), 168.24 (C-2) and 169.05 (-OCOCH3); HRMS: Calculated for C12H8F3NO3 [M+H]
+
 272.0456, found 
271.9899.  
3.3.5. 2-Oxo-4-(trifluoromethyl)-1,2-dihydro-7-yl acetate (13b)  
The title compound (13b) was obtained as white crystals in 90% yield by following the general procedure. Melting point: 
190oC; 
1
H NMR (DMSO-d6, 300 MHz): δ 2.32 (s, 3H, -OCOCH3), 6.97 (s, 1H, H-3), 7.12 (dd, 1H, J = 1.8 and 8.7 Hz, H-6), 
7.19 (d, 1H, J = 1.8 Hz, H-8) and 7.73 (d, 1H, J = 8.7 Hz, H-5); 
13
C NMR (DMSO-d6, 75.5 MHz): δ 20.98 (-OCOCH3), 
108.94, 110.91 (C- 6 and C-8), 117.40 (C-3), 121.45 (C-10), 124.27 (C-5), 125.72 (C-9), 136.00-136.42 (CF3), 140.84 (C-
4), 152.56 (C-7), 160.15 (C-2) and 168.84 (-OCOCH3); HRMS: Calculated for C12H8F3NO3 [M]+. 271.1920, found 
271.3652. 
3.3.6. 4-Hydroxyquinolin-2(1H)-one (3) 
It was obtained as yellow solid (70%); mp: 320 
o
C, (Literature value = 318-320 
o
C); 
1
H NMR (DMSO-d6, 300 MHz):  5.76 
(s, 1H, H-3), 7.11-7.78 (m, 4H, H-5, H-6, H-7 and H-8), 11.18 (brs, 1H, OH); 
13
C NMR (DMSO-d6, 75 MHz): δ 98.18 (C-3), 
114.95, 115.10 (C-6 and C-8), 121.04 (C-5), 122.62 (C-10), 130.82 (C-7), 139.13 (C-9), 162.43 (C-4), 163.57 (C-2); IR 
(KBr) νmax: 3430.12, 3094.44, 2953.09, 2861.12, 2639.30, 2364.36, 1669.52, 1633.94, 1594.78, 1560.44, 1506.18, 
1471.81, 1420.44, 1378.93, 1332.01, 1259.95, 1235.09, 1160.89, 1145.18, 1102.39, 1035.00, 909.53, 867.70, 773.96, 
762.96, 755.55, 671.97, 630.01cm
-1
; UV (methanol) λmax: 269 and 314 nm; HRMS: C9H7O2N [M]
+
: 161.7715. 
3.3.7. 2-Oxo-1,2-dihydroquinolin-4-yl acetate (4) 
It was obtained as yellow solid (85 %); mp: 220 
o
C, (Literature value= 217-219 
o
C); 
1
H NMR (DMSO-d6, 300 MHz): 2.45 
(s, 3H, -OCOCH3), 6.65 (s, 1H, H-3), 7.22-7.66 (m, 4H, H-5, H-6, H-7 and H-8), 11.89 (brs, 1H, NH); 
13
C NMR (DMSO-d6, 
75 MHz): δ 20.75 (-OCOCH3), 98.19 (C-3), 112.28, 115.48 (C-6 and C-8), 122.03 (C-5), 122.44 (C-10), 131.47 (C-7), 
138.87 (C-9), 156.04 (C-4), 162.39 (C-2), 172.04 (-OCOCH3); IR (KBr) νmax: 3396.31, 3009.90, 2965.78, 2858.41, 
1768.58, 1668.77, 1615.91, 1561.20, 1506.34, 1475.03, 1434.55, 1398.53, 1370.26, 1268.81, 1189.23, 1160.47, 1143.99, 
1078.60, 984.19, 953.88, 887.47, 770.84, 758.32, 660.04 cm
-1
; UV (methanol) λmax: 264 and 326 nm; HRMS: C11H9O3N 
[M+H]
+
: 204.1366. 
3.4. General procedure for the synthesis of 7-aminoquinolin-2(1H)-one   
1,3-Diaminobenzene (1.0 g, 9.3 mmol), was added to substituted ethyl acetoacetates (1.2 equivalent, 2-3, 6) and the 
mixture was refluxed for 20 h. It was then poured on ice (100 g) and the precipitate was filtered. The product was obtained 
through column chromatography using silica gel (100-200 mesh) in methanol/chloroform (1:99).  
3.4.1. 7-Amino-4-methylquinolin-2(1H)-one (9a)  
The title compound (9a) was obtained as yellow solid in 65% yield by following the above general procedure. Melting 
point: 271-272 oC (Literature value = 271 oC) ; 1H NMR (DMSO-d6 , 300 MHz):  δ 2.28 (s, 3H, C-4 CH3), 5.74 (brs, 2H, 
NH2), 5.96 (s, 1H, H-3), 6.37 (s, 1H, H-8), 6.46 (d, 1H, J = 8.4 Hz, H-6), 7.34 (d, 1H, J = 8.7 Hz, H-5), 11.18 (brs, 1H, NH); 
13C NMR (DMSO-d6, 75.5 MHz): δ 18.55 (C-4 CH3), 96.85, 110.48, 110.55 and 114.67 (C-3, C-6, C-8 and C-10), 125.67 
(C-5), 140.81 (C-9), 148.13 (C-4), 151.15 (C-7), 162.55 (C-2); ESI MS: Calculated for C10H10N2O [M]
+
174, found 174. 
3.4.2. N-(4-Methyl-2-oxo-1,2-dihydroquinolin-7-yl) acetamide (10a)  
The title compound (10a) was obtained as brown crystals in 60% yield by following the general procedure. Melting point: 
300
o
C (Literature value = 300 
o
C)
 
;  
1
H NMR (DMSO-d6, 300 MHz):  δ 2.09 (s, 3H, H-2`), 2.38 (s, 3H, C-4 CH3), 6.26 (s, 
1H, H-3), 7.30 (d, 1H, J = 8.7 Hz, H-6), 7.62 (d, 1H, J = 8.7 Hz, H-5), 7.99 (s, 1H, H-8), 10.197, 11.53 (2 x brs, 2H, 2 x 
NHCO); 13C NMR (DMSO-d6, 75.5 MHz):  δ 18.44 (C-4 CH3), 24.18 (C-2`), 104.37 and 113.48 (C-6 and C-8), 115.46 and 
118.89 (C-3 and C-10), 125.31 (C-5), 139.51 (C-9), 141.05 (C-4), 147.74 (C-7), 162.14 (C-2), 168.85 (C-1`); ESI MS: 
Calculated for C12H12N2O2 [M]
+.
 216, found 216.   
3.4.3. N-(2-Oxo-4-(trifluoromethyl)-1,2-dihydroquinolin-7-yl)acetamide (10b)  
The title compound (10b) was obtained as brown crystals in 90% yield by following the general procedure. Melting point: > 
300 
o
C; 
1
H NMR (DMSO-d6 , 300 MHz):  δ 2.09 (s, 3H, H-2`), 6.79 (s, 1H, H-3), 7.35 (d, 1H, J = 9.0 Hz, H-6), 7.62 (d, 1H, 
J = 8.7 Hz, H-5), 7.98 (s, 1H, H-8); 13C NMR (DMSO-d6, 75.5 MHz):  δ 24.16 (C-2`), 104.71, 108.61 (C-6 and C-8), 
114.62 (C-3), 119.16 (C-10), 120.76 (C-5), 124.84 (C-9), 136.11-136.93 (-CF3), 140.86 (C-4), 142.06 (C-7), 160.41 (C-2), 
169.12 (C-1`); HRMS: Calculated for C12H9F3N2O2 [M+Na]
+
 293.0508, found 293.0508.  
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3.5. CONCLUSION 
1
H NMR analysis of different derivatives of quinolones / coumarins led to the establishment of the following discriminative 
tools for the δ value for H-3: 
1.      It was observed that when C-4 position gets substituted with trifluoromethyl group, the proton attached with C-3 
becomes highly downfield as compared to other substituents (methyl / hydroxy / acetoxy / amino). 
2.       The hydroxy group on the benzenoid ring causes shielding when incorporated in place of methoxy group and 
reverse trend was observed in case of acetoxy group as substituent.         
3.       In case of trifluoromethyl quinolone / coumarin derivatives, the maximum deshielding was observed in case of 
acetoxy derivative, whereby the acetoxy group was placed at C-6 position of  benzenoid ring with ∆δ of around 1.55 ppm. 
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